Targeted Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type, By Target Enrichment Method, By Target Capture Type, By Application, By End Users, By Region, By Competition, 2020-2030F

Description

The Global Targeted Sequencing Market, valued at USD 3.9 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 7.33 Billion by 2030. The Global Targeted Sequencing Market centers on a next-generation sequencing technique that precisely targets and analyzes specific genomic regions, such as particular genes or exons, rather than sequencing the entire genome. This focused approach provides high-depth coverage and accuracy for selected areas, enabling efficient and cost-effective identification of genetic variants critical for various applications.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.9 Billion
Market Size 2030	USD 7.33 Billion
CAGR 2025-2030	11.1%
Fastest Growing Segment	Targeted DNA Sequencing
Largest Market	North America

Key Market Drivers

The increasing global burden of genetic disorders and cancer represents a primary driving force behind the expansion of the Global Targeted Sequencing Market. The critical need for precise diagnostic tools and methods for disease characterization fuels the demand for targeted sequencing, which offers highly accurate and in-depth analysis of specific genomic regions relevant to these conditions. This technology enables earlier detection, guides personalized treatment strategies, and facilitates monitoring for recurrence or treatment response in oncology and rare disease settings. According to the World Health Organization, in February 2024, global cancer estimates for 2022 revealed approximately 20 million new cancer cases and 9.7 million deaths, highlighting the pervasive nature of this disease and the continuous requirement for advanced diagnostic solutions. Furthermore, targeted sequencing is instrumental in identifying the underlying genetic causes of rare diseases, which collectively affect millions worldwide.

Key Market Challenges

A significant challenge impeding the growth of the Global Targeted Sequencing Market is the absence of standardized guidelines and a unified consensus regarding the multitude of next-generation sequencing platforms and techniques. This fragmented landscape directly complicates widespread clinical adoption and the crucial processes of securing reimbursement for these advanced diagnostic tests. The lack of uniform standards creates ambiguity in test validation, interpretation, and reporting across different laboratories and healthcare providers.

This absence of standardization contributes to inconsistent payer policies, as each insurer may establish varying evidentiary requirements for assessing clinical utility, leading to unpredictable coverage and payment decisions. For instance, according to the College of American Pathologists, a 2.5% reduction in payment for pathology services, which includes molecular diagnostics, is anticipated starting January 2025, reflecting ongoing pressures on reimbursement and the complexities in valuing these intricate tests. Such financial uncertainty directly deters broader integration of targeted sequencing into routine clinical practice, limiting patient access to these critical diagnostic tools and consequently hindering overall market expansion.

Key Market Trends

Artificial intelligence and machine learning integration is profoundly transforming genomic data interpretation within targeted sequencing. These advanced computational methods are essential for efficiently analyzing the vast and complex datasets generated, enabling the rapid identification of subtle genetic variants and their clinical implications. This capability significantly enhances diagnostic precision and facilitates the development of personalized therapeutic approaches. Reflecting this growing importance, according to Roche, in April 2025, the company committed $50 billion over five years to its US pharmaceutical and diagnostics operations, including the establishment of a new research and development center focused on artificial intelligence research. This strategic investment highlights the industry's reliance on AI to convert genomic information into actionable clinical intelligence.

Key Market Players

MGI Tech Co., Ltd
GENEWIZ Inc
Agilent Technologies, Inc.
Daicel Arbor Biosciences
Danaher Corporation
Illumina, Inc.
LGC Biosearch Technologies
Pacific Biosciences of California Inc
CD Genomics
F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Targeted Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Targeted Sequencing Market, By Product Type:

Kits/Panels and Assays
Instruments
Other

Targeted Sequencing Market, By Target Capture Type:

Targeted DNA Sequencing
Targeted RNA Sequencing
Others

Targeted Sequencing Market, By Target Enrichment Method:

Amplicon Sequencing
Hybridization Capture
Others

Targeted Sequencing Market, By End Users:

Academic and Research Institution
Pharmaceutical and Biotech Companies
Diagnostic & Clinical Laboratories
Other

Targeted Sequencing Market, By Application:

Oncology
Infectious Diseases
Cardiovascular Diseases
Reproductive Health
Rare Diseases
Neurological Disorders
Hereditary Diseases
Others

Targeted Sequencing Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Targeted Sequencing Market.

Available Customizations:

Global Targeted Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Targeted Sequencing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product Type (Kits/Panels and Assays, Instruments, Other)
- 5.2.2. By Target Capture Type (Targeted DNA Sequencing, Targeted RNA Sequencing, Others)
- 5.2.3. By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, Others)
- 5.2.4. By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories, Other)
- 5.2.5. By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2024)
5.3. Market Map

6. North America Targeted Sequencing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.2. By Target Capture Type
- 6.2.3. By Target Enrichment Method
- 6.2.4. By End Users
- 6.2.5. By Application
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Targeted Sequencing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product Type
    - 6.3.1.2.2. By Target Capture Type
    - 6.3.1.2.3. By Target Enrichment Method
    - 6.3.1.2.4. By End Users
    - 6.3.1.2.5. By Application
- 6.3.2. Canada Targeted Sequencing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product Type
    - 6.3.2.2.2. By Target Capture Type
    - 6.3.2.2.3. By Target Enrichment Method
    - 6.3.2.2.4. By End Users
    - 6.3.2.2.5. By Application
- 6.3.3. Mexico Targeted Sequencing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product Type
    - 6.3.3.2.2. By Target Capture Type
    - 6.3.3.2.3. By Target Enrichment Method
    - 6.3.3.2.4. By End Users
    - 6.3.3.2.5. By Application

7. Europe Targeted Sequencing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Target Capture Type
- 7.2.3. By Target Enrichment Method
- 7.2.4. By End Users
- 7.2.5. By Application
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Targeted Sequencing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product Type
    - 7.3.1.2.2. By Target Capture Type
    - 7.3.1.2.3. By Target Enrichment Method
    - 7.3.1.2.4. By End Users
    - 7.3.1.2.5. By Application
- 7.3.2. France Targeted Sequencing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product Type
    - 7.3.2.2.2. By Target Capture Type
    - 7.3.2.2.3. By Target Enrichment Method
    - 7.3.2.2.4. By End Users
    - 7.3.2.2.5. By Application
- 7.3.3. United Kingdom Targeted Sequencing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product Type
    - 7.3.3.2.2. By Target Capture Type
    - 7.3.3.2.3. By Target Enrichment Method
    - 7.3.3.2.4. By End Users
    - 7.3.3.2.5. By Application
- 7.3.4. Italy Targeted Sequencing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product Type
    - 7.3.4.2.2. By Target Capture Type
    - 7.3.4.2.3. By Target Enrichment Method
    - 7.3.4.2.4. By End Users
    - 7.3.4.2.5. By Application
- 7.3.5. Spain Targeted Sequencing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product Type
    - 7.3.5.2.2. By Target Capture Type
    - 7.3.5.2.3. By Target Enrichment Method
    - 7.3.5.2.4. By End Users
    - 7.3.5.2.5. By Application

8. Asia Pacific Targeted Sequencing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Target Capture Type
- 8.2.3. By Target Enrichment Method
- 8.2.4. By End Users
- 8.2.5. By Application
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Targeted Sequencing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product Type
    - 8.3.1.2.2. By Target Capture Type
    - 8.3.1.2.3. By Target Enrichment Method
    - 8.3.1.2.4. By End Users
    - 8.3.1.2.5. By Application
- 8.3.2. India Targeted Sequencing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product Type
    - 8.3.2.2.2. By Target Capture Type
    - 8.3.2.2.3. By Target Enrichment Method
    - 8.3.2.2.4. By End Users
    - 8.3.2.2.5. By Application
- 8.3.3. Japan Targeted Sequencing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product Type
    - 8.3.3.2.2. By Target Capture Type
    - 8.3.3.2.3. By Target Enrichment Method
    - 8.3.3.2.4. By End Users
    - 8.3.3.2.5. By Application
- 8.3.4. South Korea Targeted Sequencing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product Type
    - 8.3.4.2.2. By Target Capture Type
    - 8.3.4.2.3. By Target Enrichment Method
    - 8.3.4.2.4. By End Users
    - 8.3.4.2.5. By Application
- 8.3.5. Australia Targeted Sequencing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product Type
    - 8.3.5.2.2. By Target Capture Type
    - 8.3.5.2.3. By Target Enrichment Method
    - 8.3.5.2.4. By End Users
    - 8.3.5.2.5. By Application

9. Middle East & Africa Targeted Sequencing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Target Capture Type
- 9.2.3. By Target Enrichment Method
- 9.2.4. By End Users
- 9.2.5. By Application
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Targeted Sequencing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product Type
    - 9.3.1.2.2. By Target Capture Type
    - 9.3.1.2.3. By Target Enrichment Method
    - 9.3.1.2.4. By End Users
    - 9.3.1.2.5. By Application
- 9.3.2. UAE Targeted Sequencing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product Type
    - 9.3.2.2.2. By Target Capture Type
    - 9.3.2.2.3. By Target Enrichment Method
    - 9.3.2.2.4. By End Users
    - 9.3.2.2.5. By Application
- 9.3.3. South Africa Targeted Sequencing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product Type
    - 9.3.3.2.2. By Target Capture Type
    - 9.3.3.2.3. By Target Enrichment Method
    - 9.3.3.2.4. By End Users
    - 9.3.3.2.5. By Application

10. South America Targeted Sequencing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Target Capture Type
- 10.2.3. By Target Enrichment Method
- 10.2.4. By End Users
- 10.2.5. By Application
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Targeted Sequencing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product Type
    - 10.3.1.2.2. By Target Capture Type
    - 10.3.1.2.3. By Target Enrichment Method
    - 10.3.1.2.4. By End Users
    - 10.3.1.2.5. By Application
- 10.3.2. Colombia Targeted Sequencing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product Type
    - 10.3.2.2.2. By Target Capture Type
    - 10.3.2.2.3. By Target Enrichment Method
    - 10.3.2.2.4. By End Users
    - 10.3.2.2.5. By Application
- 10.3.3. Argentina Targeted Sequencing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product Type
    - 10.3.3.2.2. By Target Capture Type
    - 10.3.3.2.3. By Target Enrichment Method
    - 10.3.3.2.4. By End Users
    - 10.3.3.2.5. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Targeted Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. MGI Tech Co., Ltd
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. GENEWIZ Inc
15.3. Agilent Technologies, Inc.
15.4. Daicel Arbor Biosciences
15.5. Danaher Corporation
15.6. Illumina, Inc.
15.7. LGC Biosearch Technologies
15.8. Pacific Biosciences of California Inc
15.9. CD Genomics
15.10. F. Hoffmann-La Roche Ltd